April 13, 2026
Hashemi, Kannan inducted into AIMBE College of Fellows
Election is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top 2% of engineers in these fields.
Dec. 11, 2025
Mizzou ÌÇÐÄVlog´«Ã½ professor named 2025 NAI Fellow
Raghuraman Kannan is among 169 researchers receiving the prestigious honor from the National Academy of Inventors this year.
Sep. 16, 2025
Mizzou ÌÇÐÄVlog´«Ã½ faculty named Curators’ Distinguished Professors
Sheila Grant and Raghuraman Kannan have received the highest honor bestowed by the University of Missouri System.
July 8, 2025
Study: Why some lung cancer treatments stop working — and possible fixes
University of Missouri scientists discover a hidden "molecular seesaw" behind drug resistance in certain types of lung cancer, offering hope for more effective therapies.
Jan. 5, 2023
Department of Chemical and Biomedical ÌÇÐÄVlog´«Ã½ name change reflects research focus
Mizzou ÌÇÐÄVlog´«Ã½ will put more focus on research and innovations around chemical and biomedical innovations in the coming years.
Oct. 19, 2022
Reversing drug resistance in lung cancer
Raghuraman Kannan, right, and a team of researchers at the University of Missouri recently received a $2.35 million grant from the National Cancer Institute (NCI) to generate preclinical data based on their existing research around lung cancer — the required step before human clinical trials can begin. By Eric Stann | MU News Burea When someone is diagnosed with non-small cell lung cancer — one of two main forms of lung cancer — there is a 70-80% chance that after 14 months the cancer will develop a resistance to the drug therapy originally given to fight it. If…